Rebif Rebidose Titration Pack

Generic name: interferon beta-1a (intramuscular route, subcutaneous route) [ in-ter-FEER-on-BAY-ta-1a ]
Drug class:Interferons

Medically reviewed by Drugs.com. Last updated on Feb 27, 2022.

Commonly used brand name(s)

In the U.S.

• Avonex
• Avonex Pen
• Rebif
• Rebif Rebidose
• Rebif Rebidose Titration Pack

Available Dosage Forms:

• Solution
• Kit

Therapeutic Class: Immunological Agent

Pharmacologic Class: Interferon, Beta (class)

Uses for Rebif Rebidose Titration Pack

Interferon beta-1a injection is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. Interferons are natural substances that are produced in the body to help fight infections. Interferon beta-1a is a synthetic (man-made) version of these substances.

This medicine is available only with your doctor's prescription.

Before using Rebif Rebidose Titration Pack

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of interferon beta-1a injection in the pediatric population. Safety and efficacy have not been established.

Geriatric

Although appropriate studies on the relationship of age to the effects of interferon beta-1a injection have not been performed in the geriatric population, geriatric-specific problems are not expected to limit the usefulness of interferon beta-1a injection in the elderly. However, elderly patients are more likely to have age-related kidney, liver, or heart problems, which may require caution in patients receiving interferon beta-1a injection.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this me...